Page last updated: 2024-11-03

proadifen and Carcinoma, Ductal, Breast

proadifen has been researched along with Carcinoma, Ductal, Breast in 1 studies

Proadifen: An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.

Carcinoma, Ductal, Breast: An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kretschy, N1
Teichmann, M1
Kopf, S1
Atanasov, AG1
Saiko, P1
Vonach, C1
Viola, K1
Giessrigl, B1
Huttary, N1
Raab, I1
Krieger, S1
Jäger, W1
Szekeres, T1
Nijman, SM1
Mikulits, W1
Dirsch, VM1
Dolznig, H1
Grusch, M1
Krupitza, G1

Other Studies

1 other study available for proadifen and Carcinoma, Ductal, Breast

ArticleYear
In vitro inhibition of breast cancer spheroid-induced lymphendothelial defects resembling intravasation into the lymphatic vasculature by acetohexamide, isoxsuprine, nifedipin and proadifen.
    British journal of cancer, 2013, Feb-19, Volume: 108, Issue:3

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Acetohexamide; Antineoplastic Combined Chemotherapy Prot

2013